辰光医疗(430300) - 2024 Q4 - 年度业绩预告

Financial Performance - The company's net profit attributable to shareholders for 2024 is projected to be -58 million RMB, a decrease of 392.25% compared to -11.78 million RMB in the same period last year[5] - The significant decline in profit is primarily due to a substantial drop in gross profit, with sales revenue from MRI equipment and components decreasing due to a challenging domestic medical equipment market[7] Operating Expenses - The company is experiencing increased operating expenses as it continues to invest in marketing and R&D despite declining revenues, leading to higher period costs in 2024[7]